Acceleron Ends ACE-083 FSHD Testing After Phase II Failure

 
• By Sten Stovall
  
Muscular_Dystrophy
Acceleron Has Discontinued ACE-083 in facioscapulohumeral muscular dystrophy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapeutic Category